| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From Bethesda, MD (P.B.); CJD Surveillance Unit, Hôpital de la Salpêtrière, Paris, France (J.-P.B.); Institute of Child Health, London, England (M.P.); and Department of Neurology, Higashiyamato Hospital, Japan (T.S.).
* To whom correspondence should be addressed. E-mail: paulwbrown{at}comcast.net.
Abstract-- The outbreaks of iatrogenic Creutzfeldt-Jakob disease (CJD) from cadaveric human growth hormone and dura mater are winding down and, like the only other environmentally acquired form of CJD (variant CJD due to infection with the agent of bovine spongiform encephalopathy), iatrogenic disease seems to have reached its high water mark during the 1990s. The total number of cases has reached 405, and the diminishing number of new cases is due to extremely long incubation periods from infections acquired before 1985 (up to 23 years for dura mater and 36 years for growth hormone). Although no cases associated with surgical or other invasive procedures have been identified during the past several decades, the recent discovery of three transfusion-associated variant CJD infections has provoked new concerns about the possibility of further secondary transmissions from operative procedures as well as blood and tissue donations. Therefore, at least in those countries in which variant CJD has occurred, precautionary measures must continue for the indefinite future.
This article has been cited by other articles:
|
|
 |
|
  L Priano, G Giaccone, M Mangieri, G Albani, L Limido, A Brioschi, L Pradotto, L Orsi, P Mortara, P Fociani, et al. An atypical case of sporadic fatal insomnia J. Neurol. Neurosurg. Psychiatry, August 1, 2009; 80(8): 924 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Xiao, L. Miravalle, J. Yuan, J. McGeehan, Z. Dong, R. Wyza, G. T. MacLennan, A. M. Golichowski, G. Kneale, N. King, et al. Failure to Detect the Presence of Prions in the Uterine and Gestational Tissues from a Gravida with Creutzfeldt-Jakob Disease Am. J. Pathol., May 1, 2009; 174(5): 1602 - 1608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hizume, A. Kobayashi, K. Teruya, H. Ohashi, J. W. Ironside, S. Mohri, and T. Kitamoto Human Prion Protein (PrP) 219K Is Converted to PrPSc but Shows Heterozygous Inhibition in Variant Creutzfeldt-Jakob Disease Infection J. Biol. Chem., February 6, 2009; 284(6): 3603 - 3609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Klug, H. Wand, A. Boyd, M. Law, S. Whyte, J. Kaldor, C. L. Masters, and S. Collins Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster Brain, February 1, 2009; 132(2): 493 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Collinge Lessons of kuru research: background to recent studies with some personal reflections Phil Trans R Soc B, November 27, 2008; 363(1510): 3689 - 3696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D.F Wadsworth, S. Joiner, J. M Linehan, E. A Asante, S. Brandner, and J. Collinge The origin of the prion agent of kuru: molecular and biological strain typing Phil Trans R Soc B, November 27, 2008; 363(1510): 3747 - 3753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Brandner, J. Whitfield, K. Boone, A. Puwa, C. O'Malley, J. M Linehan, S. Joiner, F. Scaravilli, I. Calder, M. P. Alpers, et al. Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease Phil Trans R Soc B, November 27, 2008; 363(1510): 3755 - 3763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. F. Wadsworth, S. Joiner, J. M. Linehan, M. Desbruslais, K. Fox, S. Cooper, S. Cronier, E. A. Asante, S. Mead, S. Brandner, et al. Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice PNAS, March 11, 2008; 105(10): 3885 - 3890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Brown Transmissible spongiform encephalopathy in the 21st century: Neuroscience for the clinical neurologist Neurology, February 26, 2008; 70(9): 713 - 722. [Full Text] [PDF]
|
|
|
|
|
|
A. Kobayashi, M. Asano, S. Mohri, and T. Kitamoto Cross-sequence Transmission of Sporadic Creutzfeldt-Jakob Disease Creates a New Prion Strain J. Biol. Chem., October 12, 2007; 282(41): 30022 - 30028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Noguchi-Shinohara, T. Hamaguchi, T. Kitamoto, T. Sato, Y. Nakamura, H. Mizusawa, and M. Yamada Clinical features and diagnosis of dura mater graft-associated Creutzfeldt-Jakob disease Neurology, July 24, 2007; 69(4): 360 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Heinemann, A. Krasnianski, B. Meissner, D. Varges, K. Kallenberg, W. J. Schulz-Schaeffer, B. J. Steinhoff, E. M. Grasbon-Frodl, H. A. Kretzschmar, and I. Zerr Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance Brain, May 1, 2007; 130(5): 1350 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Peden, D. L. Ritchie, H. P. Uddin, A. F. Dean, K. A. F. Schiller, M. W. Head, and J. W. Ironside Abnormal prion protein in the pituitary in sporadic and variant Creutzfeldt-Jakob disease J. Gen. Virol., March 1, 2007; 88(3): 1068 - 1072. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
